R&D Team
KOSHINÉ has an experienced R&D team consisting of outstanding experts from China and abroad. The core team members are all PhDs in the fields of biochemistry and medicine with over 20+ years of experience in clinical research, pharmacology, drug development, etc. The company has obtained and applied for more than 110 patents.
The team is currently focusing on dermatology field, especially those related to androgen receptors, and has developed diverse product pipeline. Based on in-depth industry insight and market research, the team formulates product development strategies, designs and develops new products, and continuously improves and upgrades existing products.
Dr. Youzhi TONG
Founder, Chairman & CEO
25+ years of experience in Biopharm R&D and management
Former VP of Angion Biomedica in the U.S.
Former Assistant Professor of Albert Einstein College of Medicine
Ph.D. in Pharmacology from Cornell University; MA and BA in Chemistry from Peking University
Dr. Kevin Ni
Executive Director, Chief Medical Officer
25+ years of experience in clinical development, pharmacovigilance and clinical quality management
Served in AstraZeneca and other world's leading international pharmaceutical giants
Led approvals for 6 global NDAs and numerous INDs, and well experienced in global regulatory communication
Ph.D. from School of Medicine, Temple University; BA from Southeastern University School, PRC
Dr. Jie CHEN
Senior Deputy General Manager
10+ years of experience in drug R&D
Published around 20 papers and holds 4 invention patents
Adjunct visiting researcher at Suzhou Research Institute, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences
Ph.D. in Organic Chemistry from Chinese Academy of Sciences
Dr. Ruo XU
Vice President, Business Development
20+ years of experience in the pharmaceutical industry
Former Chief Scientist of Schering-Plough, and worked in Merck for more than 15 years
Responsible for the design and synthesis of more than 7 small molecule inhibitors
Ph.D. in Chemistry from Columbia University; BA in Chemistry from Peking University
Dr. Zhihua REN
Vice President, Head of Institute of R&D
20+ years of experience in medicine, oncology and stem cell translational medicine
Served in MEDx Translational Medicine and CAMS & PUMC Fangzhou R&D center
Postdoctoral and research fellow in at the University of Chicago, RUSH University Medical Center and UMDNJ
Ph.D. in Science from Shanghai Jiao Tong University, MA and BA in Medicine from Qingdao University
Clinical Trials
Qualifications